Women with breast cancer who are receiving dose-dense paclitaxel are more likely to experience paclitaxel-induced peripheral neuropathy (PIPN) when compared with women who receive the treatment weekly,...
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
Researchers updated the 2014 INCOG Guidelines that outline how clinicians should approach cognitive rehabilitation for individuals who have traumatic brain injury.